181 related articles for article (PubMed ID: 19571827)
1. Masked, white coat and sustained hypertension: comparison of target organ damage and psychometric parameters.
Konstantopoulou AS; Konstantopoulou PS; Papargyriou IK; Liatis ST; Stergiou GS; Papadogiannis DE
J Hum Hypertens; 2010 Mar; 24(3):151-7. PubMed ID: 19571827
[TBL] [Abstract][Full Text] [Related]
2. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
[TBL] [Abstract][Full Text] [Related]
3. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
Shimada K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimamoto K; Tanaka H; Yoshiike N
Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of white-coat response in patients with treated hypertension.
MacDonald MB; Laing GP; Wilson MP; Wilson TW
CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
[TBL] [Abstract][Full Text] [Related]
5. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
6. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
[TBL] [Abstract][Full Text] [Related]
7. Aortic elastic properties and left ventricular diastolic function in white-coat hypertensive individuals.
Erdogan D; Caliskan M; Gullu H; Yildirim I; Ozer I; Ozgul A; Muderrisoglu H
Blood Press Monit; 2006 Aug; 11(4):191-8. PubMed ID: 16810029
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
[TBL] [Abstract][Full Text] [Related]
9. Routine use of ambulatory blood pressure monitoring in potential living kidney donors.
Ommen ES; Schröppel B; Kim JY; Gaspard G; Akalin E; de Boccardo G; Sehgal V; Lipkowitz M; Murphy B
Clin J Am Soc Nephrol; 2007 Sep; 2(5):1030-6. PubMed ID: 17702722
[TBL] [Abstract][Full Text] [Related]
10. Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population.
Wang GL; Li Y; Staessen JA; Lu L; Wang JG
J Hypertens; 2007 Dec; 25(12):2398-405. PubMed ID: 17984660
[TBL] [Abstract][Full Text] [Related]
11. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives.
Conen D; Dieterle T; Utech K; Rimner M; Martina B
Hypertens Res; 2006 Jun; 29(6):411-5. PubMed ID: 16940703
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
J Am Coll Cardiol; 2005 Aug; 46(3):508-15. PubMed ID: 16053966
[TBL] [Abstract][Full Text] [Related]
14. Metabolic risk factors in white coat hypertensives.
Marchesi E; Perani G; Falaschi F; Negro C; Catalano O; Ravetta V; Finardi G
J Hum Hypertens; 1994 Jul; 8(7):475-9. PubMed ID: 7932508
[TBL] [Abstract][Full Text] [Related]
15. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study.
Ben-Dov IZ; Kark JD; Mekler J; Shaked E; Bursztyn M
J Hypertens; 2008 Apr; 26(4):699-705. PubMed ID: 18327079
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure variability in elderly persons with white-coat and masked hypertension compared to those with normotension and sustained hypertension.
Cacciolati C; Tzourio C; Hanon O
Am J Hypertens; 2013 Mar; 26(3):367-72. PubMed ID: 23382487
[TBL] [Abstract][Full Text] [Related]
17. White-coat hypertension and cardiovascular risk.
Cerasola G; Cottone S; Nardi E; D'Ignoto G; Volpe V; Mulé G; Carollo C
J Cardiovasc Risk; 1995 Dec; 2(6):545-9. PubMed ID: 8665373
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of strategy for the detection of white coat hypertension based on ambulatory and home blood pressure monitoring.
Stergiou GS; Alamara CV; Skeva II; Mountokalakis TD
J Hum Hypertens; 2004 Feb; 18(2):85-9. PubMed ID: 14730322
[TBL] [Abstract][Full Text] [Related]
19. The mean platelet volume in patients with essential and white coat hypertension.
Coban E; Yazicioglu G; Berkant Avci A; Akcit F
Platelets; 2005 Nov; 16(7):435-8. PubMed ID: 16236605
[TBL] [Abstract][Full Text] [Related]
20. Determinants of masked hypertension in the general population: the Finn-Home study.
Hänninen MR; Niiranen TJ; Puukka PJ; Mattila AK; Jula AM
J Hypertens; 2011 Oct; 29(10):1880-8. PubMed ID: 21841499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
